Evidence map›Paper›PMID 33260360›Full record

ArticleCancers2020

Role of Human Papillomavirus Infection in Head and Neck Cancer in Italy: The HPV-AHEAD Study.

Marta Tagliabue, Marisa Mena, Fausto Maffini, Tarik Gheit, Beatriz Quirós Blasco, Dana Holzinger, Sara Tous, Daniele Scelsi, Debora Riva, Enrica Grosso and 25 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. A systematic review and network meta-analysis of therapies for locally advanced head and neck squamous cell carcinoma with different HPV status.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma.Journal of cancer research and clinical oncology · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Papillomavirus Infection and Prevention: How Much Does the Sicilian Population Know? An Observational Study.International journal of environmental research and public health · 2022
    Observational
  17. Article
  18. Accuracy of high-risk HPV DNA PCR, p16BMC infectious diseases · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors at 14 institutions in 7 countries.

Marta TagliabueDivision of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0002-7879-4846
Marisa MenaCancer Epidemiology Research Program, Catalan Institute of Oncology-Bellvitge Biomedical Research Institute (ICO-IDIBELL), L'Hospitalet de Llobregat, 08908 Barcenola, Spain.ORCID 0000-0003-2163-892X
Fausto MaffiniDivision of Pathology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0002-4554-8956
Tarik GheitInfections and Cancer Biology Group, International Agency for Research on Cancer (IARC), 69372 Lyon, France.
Beatriz Quirós BlascoCancer Epidemiology Research Program, Catalan Institute of Oncology-Bellvitge Biomedical Research Institute (ICO-IDIBELL), L'Hospitalet de Llobregat, 08908 Barcenola, Spain.
Dana HolzingerDeutsches Krebsforschungszentrum (DKFZ), 69120 Heidelberg, Germany.
Sara TousCancer Epidemiology Research Program, Catalan Institute of Oncology-Bellvitge Biomedical Research Institute (ICO-IDIBELL), L'Hospitalet de Llobregat, 08908 Barcenola, Spain.ORCID 0000-0002-5423-7092
Daniele ScelsiDivision of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Debora RivaDivision of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0001-5433-9497
Enrica GrossoDivision of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Francesco ChuDivision of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Eric LucasInfections and Cancer Biology Group, International Agency for Research on Cancer (IARC), 69372 Lyon, France.ORCID 0000-0002-1252-1925
Ruediger RidderRoche mtm laboratories, 69117 Mannheim, Germany.
Susanne RrehmRoche mtm laboratories, 69117 Mannheim, Germany.
Johannes Paul BogersLaboratory for Cell Biology and Histology, University of Antwerp, 2610 Antwerp, Belgium.
Daniela LepantoDivision of Pathology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Belén Lloveras RubioHospital del Mar, 08003 Barcelona, Spain.
Rekha Vijay KumarKidwai Memorial Institute of Oncology, Bangalore, Karnataka 560029, India.
Nitin GanganeMahatma Gandhi Institute of Medical Sciences, Sevagram, Wardha, Maharashtra State 442102, India.
Omar ClaveroCancer Epidemiology Research Program, Catalan Institute of Oncology-Bellvitge Biomedical Research Institute (ICO-IDIBELL), L'Hospitalet de Llobregat, 08908 Barcenola, Spain.
Michael PawlitaDeutsches Krebsforschungszentrum (DKFZ), 69120 Heidelberg, Germany.
Devasena AnantharamanRajiv Gandhi Centre for Biotechnology, Poojappura, Thiruvananthapuram, Kerala 695012, India.
Madhavan Radhakrishna PillaiRajiv Gandhi Centre for Biotechnology, Poojappura, Thiruvananthapuram, Kerala 695012, India.
Paul BrennanSection of Genetics, International Agency for Research on Cancer (IARC), 69372 Lyon, France.
Rengaswamy SankaranarayananResearch Triangle Institute (RTI) International India, New Delhi 110001, India.
Marc ArbynUnit of Cancer Epidemiology/Belgian Cancer Centre, Sciensano, 1050 Brussels, Belgium.
Francesca LombardiData Management, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Miren TabernaMedical Oncology Department, Catalan Institute of Oncology (ICO), ONCOBELL, IDIBELL, L'Hospitalet de Llobregat, 08035 Barcelona, Spain.
Sara GandiniDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0002-1348-4548
Fausto ChiesaDivision of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Mohssen AnsarinDivision of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Laia AlemanyCancer Epidemiology Research Program, Catalan Institute of Oncology-Bellvitge Biomedical Research Institute (ICO-IDIBELL), L'Hospitalet de Llobregat, 08908 Barcenola, Spain.
Massimo TommasinoInfections and Cancer Biology Group, International Agency for Research on Cancer (IARC), 69372 Lyon, France.
Susanna ChioccaDepartment of Experimental Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0002-9721-0850
The Hpv-Ahead Study Group
European Institute of Oncology · ITInstituto de Salud Carlos III · ESCentre international de recherche sur le cancer · FRGerman Cancer Research Center · DERajiv Gandhi Centre for Biotechnology · INData Management (Italy) · ITHospital Del Mar · ESInstitut d'Investigació Biomédica de Bellvitge · ESKidwai Memorial Institute of Oncology · INMahatma Gandhi Institute of Medical Sciences · INRoche Pharma AG (Germany) · DERoche (United States) · USSciensano (Belgium) · BEUniversity of Antwerp · BE

Funding

World Health Organization 001
6 · The paper itself

Abstract

Literature on the role of human papillomavirus (HPV) in head and neck cancer (HNC) in Italy is limited, especially for non-oropharyngeal tumours. Within the context of the HPV-AHEAD study, we aimed to assess the prognostic value of different tests or test algorithms judging HPV carcinogenicity in HNC and factors related to HPV positivity at the European Institute of Oncology. We conducted a retrospective cohort study (2000-2010) on a total of 696 primary HNC patients. Formalin-fixed, paraffin-embedded cancer tissues were studied. All HPV-DNA-positive and a random sample of HPV-DNA-negative cases were subjected to HPV-E6*I mRNA detection and p16

Indexed as

head and neck cancerhuman papillomavirushuman papillomavirus diagnosisoropharyngeal cancervirus-related cancers

Identifiers

PMID33260360
PMCPMC7760748
OpenAlexW3107865107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.